Blau Farmacêutica S.A.

BOVESPA:BLAU3 Rapport sur les actions

Capitalisation boursière : R$2.6b

Blau Farmacêutica Gestion

Gestion contrôle des critères 0/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

Marcelo Hahn

Directeur général

n/a

Rémunération totale

Pourcentage du salaire du PDGn/a
Durée du mandat du directeur généralno data
Propriété du PDG83.3%
Durée moyenne d'occupation des postes de directionless than a year
Durée moyenne du mandat des membres du conseil d'administrationpas de données

Mises à jour récentes de la gestion

Recent updates

Results: Blau Farmacêutica S.A. Exceeded Expectations And The Consensus Has Updated Its Estimates

Nov 07
Results: Blau Farmacêutica S.A. Exceeded Expectations And The Consensus Has Updated Its Estimates

Blau Farmacêutica S.A.'s (BVMF:BLAU3) 25% Share Price Surge Not Quite Adding Up

Nov 06
Blau Farmacêutica S.A.'s (BVMF:BLAU3) 25% Share Price Surge Not Quite Adding Up

Blau Farmacêutica S.A.'s (BVMF:BLAU3) 31% Price Boost Is Out Of Tune With Earnings

Aug 29
Blau Farmacêutica S.A.'s (BVMF:BLAU3) 31% Price Boost Is Out Of Tune With Earnings

Is Blau Farmacêutica (BVMF:BLAU3) A Risky Investment?

Jun 28
Is Blau Farmacêutica (BVMF:BLAU3) A Risky Investment?

Lacklustre Performance Is Driving Blau Farmacêutica S.A.'s (BVMF:BLAU3) 26% Price Drop

Feb 01
Lacklustre Performance Is Driving Blau Farmacêutica S.A.'s (BVMF:BLAU3) 26% Price Drop

What Does The Future Hold For Blau Farmacêutica S.A. (BVMF:BLAU3)? These Analysts Have Been Cutting Their Estimates

May 14
What Does The Future Hold For Blau Farmacêutica S.A. (BVMF:BLAU3)? These Analysts Have Been Cutting Their Estimates

Blau Farmacêutica S.A. Just Missed EPS By 18%: Here's What Analysts Think Will Happen Next

Feb 24
Blau Farmacêutica S.A. Just Missed EPS By 18%: Here's What Analysts Think Will Happen Next

Getting In Cheap On Blau Farmacêutica S.A. (BVMF:BLAU3) Is Unlikely

Oct 14
Getting In Cheap On Blau Farmacêutica S.A. (BVMF:BLAU3) Is Unlikely

Robust Earnings May Not Tell The Whole Story For Blau Farmacêutica (BVMF:BLAU3)

Aug 17
Robust Earnings May Not Tell The Whole Story For Blau Farmacêutica (BVMF:BLAU3)

PDG

Marcelo Hahn

no data

Titularisation

Mr. Marcelo Rodolfo Hahn is the Founder and serves as Controller & Chief Executive Officer at Blau Farmacêutica S/A and serves as its Deputy Chairman of the Board. Mr. Hahn served as President at Blau Farm...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Marcelo Hahn
Founderno datapas de données83.3%
R$ 2.2b
Douglas Rodrigues
CFO & Investor Relations Officer2.8yrspas de donnéespas de données
Vanderlei Schiavo
Chief Technologyless than a yearpas de donnéespas de données
Roberto Altieri
Chief Legal Officerno datapas de donnéespas de données
Ana Luzia Ivanov
Chief Peopleless than a yearpas de donnéespas de données
Roberto Carlos de Morais
Chief M&A and Operations (USA and Europe) Officer & Directorless than a yearpas de donnéespas de données
Eliza Saito
Chief Quality Officerless than a yearpas de donnéespas de données
Eliana Sueco Samano
Chief Medical Officerless than a yearpas de donnéespas de données
Amaro de Souza Junior
Chief Business Unit Officer of Onco-Hematology and Specialtiesless than a yearpas de donnéespas de données
Milton Rizo
Chief Industrial Operations Officerless than a yearpas de donnéespas de données
Uilberson da Silva
Chief Researchless than a yearpas de donnéespas de données
Erica Maluf
Chief Regulatory Affairs Officerless than a yearpas de donnéespas de données

0.08yrs

Durée moyenne de l'emploi

Gestion expérimentée: L'équipe de direction de BLAU3 n'est pas considérée comme expérimentée (ancienneté moyenne 0.1 ans), ce qui suggère une nouvelle équipe.